S, B., BV, F., G, C., J, B., E, B., B, G., & S, K. (2026). Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis. Therapeutic advances in respiratory disease, 20, 17534666251410246. https://doi.org/10.1177/17534666251410246
Chicago Style (17th ed.) CitationS, Blankenship, Flueckiger BV, Caleb G, Bailey J, Baker E, Garcia B, and Krick S. "Assessment of Efficacy and Tolerability of Elexacaftor-tezacaftor-ivacaftor in an Observational Cohort Study of "Aged" People with Cystic Fibrosis." Therapeutic Advances in Respiratory Disease 20 (2026): 17534666251410246. https://doi.org/10.1177/17534666251410246.
MLA (9th ed.) CitationS, Blankenship, et al. "Assessment of Efficacy and Tolerability of Elexacaftor-tezacaftor-ivacaftor in an Observational Cohort Study of "Aged" People with Cystic Fibrosis." Therapeutic Advances in Respiratory Disease, vol. 20, 2026, p. 17534666251410246, https://doi.org/10.1177/17534666251410246.
